Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
about
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine ReceptorsClinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions.The determination of crystal structures of active pharmaceutical ingredients from X-ray powder diffraction data: a brief, practical introduction, with fexofenadine hydrochloride as example.Stress-induced visceral hypersensitivity in maternally separated rats can be reversed by peripherally restricted histamine-1-receptor antagonistsStructure determination of fexofenadine-α-cyclodextrin complex by quantitative 2D ROESY analysis and molecular mechanics studies.Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.Identification and Characterization of an Oxidative Degradation Product of Fexofenadine, Development and Validation of a Stability-Indicating RP-UPLC Method for the Estimation of Process Related Impurities and Degradation Products of Fexofenadine inIntestinal drug absorption and bioavailability: beyond involvement of single transport function.Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials.MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine.Facial thermography is a sensitive tool to determine antihistaminic activity: comparison of levocetirizine and fexofenadine.HPLC Determination of Fexofenadine in Human Plasma For Therapeutic Drug Monitoring and Pharmacokinetic Studies.The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique.Evaluating the Anti-nociceptive and Anti-inflammatory Effects of Ketotifen and Fexofenadine in Rats.Roles of histamine and its receptors in allergic and inflammatory bowel diseases.Current industrial practices of assessing permeability and P-glycoprotein interactionThe different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil.Clinical pharmacokinetics of fexofenadine enantiomers.Membrane Assays to Characterize Interaction of Drugs with ABCB1.Study of the Complexation Behaviour of Fexofenadine with β-Cyclodextrin.The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans.Does Ethnic Variability Exist in the Systemic Exposures of OATP1A2 Substrates-Fexofenadine in Taiwanese?Development of validated stability-indicating chromatographic method for the determination of fexofenadine hydrochloride and its related impurities in pharmaceutical tablets.Palladium-catalyzed α-arylation of zinc enolates of esters: reaction conditions and substrate scope.Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aidInfluence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS.Fexofenadine reduces nasal congestion in perennial allergic rhinitis.A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis.Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine.Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.Method for predicting the risk of drug-drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein.Capsaicin pretreatment enhanced the bioavailability of fexofenadine in rats by P-glycoprotein modulation: in vitro, in situ and in vivo evaluation.The influence of piperine on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers.Enantioselective uptake of fexofenadine by Caco-2 cells as model intestinal epithelial cells.
P2860
Q26827568-D804967E-6FD2-4323-8308-44B23ECBFFBDQ30234940-7C3AD980-A63A-456E-84DF-6DD53793C650Q30891655-DC7B6D0C-6F26-40CD-BF85-4F59A57130BEQ31119613-E2A64F87-ADCD-447B-BA2C-E5D74F403FA6Q34194937-AE8CA8B6-80C2-4CA2-AA38-2E3DD37E5748Q34221237-0658DEC1-C67A-44DA-A381-41808B113FE6Q34337549-0AFB0D05-770E-464D-9EF7-720D3FF2D859Q34381272-C7DC9C50-1F9F-435C-9113-4EA6FFB183EEQ35153169-1818D2EF-8D2D-4A9A-B52D-A531C5ABB080Q35627751-AEC35415-15A1-46C0-8639-7F9199F897F8Q35803858-A802BD52-0592-4C11-BBA0-0EAAABF5A443Q35827655-95F891DF-F5D3-4AF0-9EAC-6082E6651623Q35844186-46BDD7CB-C535-4505-9173-D58E70DFC7DFQ35846680-60AC2575-23D7-4698-B175-BC09E47C591FQ35895241-77892278-FFB2-44C1-8524-E9665A163B44Q36132180-364F040A-D5E3-4FA7-B6C7-0EA0A258883EQ36439145-FF7C4C05-7CBD-4C0B-A771-B65F8C2159A8Q36729143-7A0FFC52-9F89-400B-B823-6E0A66EAE1BCQ37201689-3F2BD764-EAA2-47C0-8593-EBEB3B6DBEE7Q37641373-FAA37149-E9FD-4DC5-8D01-937997F58EE2Q38880731-625FB3AC-386C-48D3-B227-BC55557276A4Q39274481-1D0790F7-42F6-46C3-88C2-239520893F1BQ39810813-D2F46B6F-F85D-4D33-891B-F3C7906BA9B7Q40075009-BCB5A69E-2AB1-46CB-BB58-189917DD70CBQ40988446-7D51CDDA-AA1E-4C0E-AB9A-08D68311D6F0Q41851554-C3E6E552-4857-418D-8AB7-FFF06A057710Q41988830-28093988-0EB7-412F-825D-EE5750E31B49Q42907834-4599C2C5-16A3-46A6-8B9F-1E89CCE871E2Q43067629-A42F4DA7-1E5A-41FF-BD64-A4CD8BDE1AB8Q43795633-19294FB3-0272-4ACF-A6E6-9AD603A45E30Q43987754-BB6C96FB-82E9-4462-8AD7-DF1445FC11D1Q43987756-CD45EFE5-FD42-46C1-A987-31201AAB0A7AQ44173557-83C14F44-D34C-43A3-BADE-9AB25C4D9EA4Q45184664-32AC6515-7327-439D-8F70-D1CB7DC0CAACQ45353676-75647A8A-3BA6-4522-9D13-BE663291E5D0Q46974293-58906180-C9A5-4EB0-892E-EF8EC77EE6C7Q47695462-2C6ED5F0-46B0-417F-8A79-47B8DFF83A77Q50945590-EE0F2919-147B-4804-8930-4D9140B7F355Q51008396-EB763286-AA3F-480E-9F41-80DEC7DAB20AQ51291327-EC10B015-E7CB-4AD7-9A28-9CA2FFBBAB45
P2860
Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Fexofenadine: a review of its ...... chronic idiopathic urticaria.
@ast
Fexofenadine: a review of its ...... chronic idiopathic urticaria.
@en
type
label
Fexofenadine: a review of its ...... chronic idiopathic urticaria.
@ast
Fexofenadine: a review of its ...... chronic idiopathic urticaria.
@en
prefLabel
Fexofenadine: a review of its ...... chronic idiopathic urticaria.
@ast
Fexofenadine: a review of its ...... chronic idiopathic urticaria.
@en
P1433
P1476
Fexofenadine: a review of its ...... chronic idiopathic urticaria.
@en
P2093
P304
P356
10.2165/00003495-200059020-00020
P577
2000-02-01T00:00:00Z
P6179
1007980184